Resources

News

News from Vox.Bio

Summer Social

For Vox.Bio’s Summer Social event this year we headed out into (a very hot and...

VoxBio team

Managing cancer patients during the COVID-19 pandemic

COVID-19 has impacted all aspects of clinical care globally – no doubt. Amid efforts put...

VoxBio team

We have launched our new London Office!

In January 2018, we opened our first London office, this was a significant step in...

VoxBio team

BHBIA Conference 2019

On 13th and 14th May 2019 BHBIA members descended on a hotel in Windsor for...

VoxBio team

Key Insights from ESMO 2019

The dust has just started to settle now on ESMO 2019, which certainly delivered when...

VoxBio team

Why focus groups can give you more…

As the pharma space continues on its ever-increasingly competitive trajectory, sometimes understanding the ‘why’ is...

VoxBio team

How We Use Secondary Landscape Analysis to Build Confidence in Our Research Insights

We are coming towards the end of a qualitative research project and so far, so...

VoxBio team

Celebrating Five Years

The teams from Vox.Bio and Cambridge Healthcare Research, celebrated our five-year anniversary last week. We...

VoxBio team

BIO Asia Taiwan 2019 Highlights

At Vox.Bio, we believe it is essential for us to keep up to date with...

VoxBio team

Findacure Rare Disease Showcase

The teams at Vox.Bio and Cambridge Healthcare Research, are really passionate about the therapeutic areas...

VoxBio team

Is the era of PowerPoint over?

Vox.Bio has just returned from a thought provoking EphMRA conference in Warsaw. A significant number...

VoxBio team

Empowering patients with pick and mix management tools

Whilst hybrid closed loop systems dominated the sessions and conference narrative at the American Diabetes...

VoxBio team

Happy Holidays!!

Vox.Bio celebrated the holiday season with a lunch in London for our UK based team....

VoxBio team

How does switching to biosimilars effect patients?

On October 16th AbbVie’s blockbuster Humira will face competition from at least four biosimilars in...

VoxBio team

CAR-T Therapies and the Challenge of Pricing Research

NHS England has become the first EU country to approve a full access deal for...

VoxBio team

‘tis the Season for Giving

With only a few days left until Christmas, Vox.Bio would like to wish happy holidays...

VoxBio team

Can Consumer Technology Really Improve Long Term Health Outcomes?

The preliminary results of the Apple Heart Study highlight the potential role that consumer digital...

VoxBio team

Everything you need to know about the use of Conjoint in Health Market Research

“Conjoint”, especially in the context of healthcare research, can be considered a daunting and scary...

VoxBio team

Why the First 10 Minutes of Qualitative Research are so Important

When budgets are tight and there is a lot of content to cover clients often...

VoxBio team

Market Research with Oncology Patients

Market research with onocology patients, even those with metastatic or terminal diagnosis is not out...

VoxBio team

UEGW Highlights

Immunology is one of Vox.Bio’s therapeutic areas of expertise and there is a lot happening...

VoxBio team

A Quick Guide to MaxDiff

MaxDiff, also known as best-worst scaling, is a quantitative tool providing prioritisation of needs, attributes...

VoxBio team

The Research Ripple Effect

The BHBIA’s Annual Conference did not disappoint again this year. The conference topic ‘The Ripple...

VoxBio team

ASCO Highlights

The largest clinical oncology conference provided an insight into the future of oncology care from...

VoxBio team